Stockreport

Kymera's Q4 Loss Wider Than Expected, Pipeline in Focus [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF In the year-ago quarter, Kymera reported a loss of 25 cents per share. The year-over-year deterioration was due to lower collaboration revenues and higher operating ex [Read more]